Zyon Ayni, Code Pharma Founder and CEO, shared his knowledge about the beginning of the process of Codivir medication. “We have already found an effective way to combat HIV infected cells and started studies where we are targeting cancer cells with the same mechanism that kills HIV affected cells”, Ayni told Global Trend Monitor.
“The drug has been given to stage 4 cancer patients and we saw the elimination of many cancer cells. We are looking to stabilize the medication so it can reach more cancer cells”, Ayni added.
